Related Experiment Video
Updated: Aug 8, 2026
09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Potential tuberculostatic agent: micelle-forming pyrazinamide prodrug
Marcia Silva1, Nara L Ricelli, Omar El Seoud
1Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, Brazil. silvam@fcfar.unesp.br
Archiv Der Pharmazie
|May 12, 2006
Summary
Researchers developed a novel pyrazinamide derivative (PEG-PASP-PZA) using a copolymer. This new micelle-forming drug conjugate showed enhanced anti-Mycobacterium activity compared to the original pyrazinamide.
Area of Science:
- Polymer Chemistry
- Drug Delivery Systems
- Microbiology
Background:
- Pyrazinamide is a crucial first-line anti-tuberculosis drug.
- Drug resistance and suboptimal delivery limit pyrazinamide efficacy.
- Copolymer-drug conjugates offer potential for improved therapeutic outcomes.
Purpose of the Study:
- To synthesize and characterize a novel pyrazinamide-copolymer conjugate.
- To evaluate the anti-Mycobacterium activity of the developed conjugate.
- To assess the micellar properties of the new derivative.
Main Methods:
- Condensation of pyrazinamide with poly(ethylene glycol)-poly(aspartic acid) (PEG-PASP) copolymer.
- Determination of critical micelle concentration (CMC) using Sudan III solubility.
- Measurement of micelle diameter via dynamic light scattering (DLS).
- In vitro anti-Mycobacterium activity assays.
Main Results:
- A novel micelle-forming copolymer derivative, PEG-PASP-PZA, was successfully synthesized.
- The critical micelle concentration (CMC) of PEG-PASP-PZA was determined.
- Dynamic light scattering revealed a mean micelle diameter of 78.2 nm for PEG-PASP-PZA.
- The PEG-PASP-PZA conjugate demonstrated enhanced anti-Mycobacterium activity compared to free pyrazinamide.
Conclusions:
- The synthesized PEG-PASP-PZA conjugate forms stable micelles.
- This novel pyrazinamide derivative exhibits improved antimycobacterial efficacy.
- Copolymer conjugation represents a promising strategy for enhancing pyrazinamide's therapeutic potential.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...